Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Gastroenterology
Movement disorders
Questions discussed in this category
In patients chronically treated for Wilson's disease with trientine hydrochloride (Syprine®), would you expect development of neurologic symptoms?
1 Answer available
14787
Papers discussed in this category
Gut, 2006 May 18
Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Related Topics in Gastroenterology
Radiation Oncology
Gynecologic Cancers
Palliation
Gastrointestinal Cancers
Genitourinary Cancers
Melanoma/Skin Cancer
Pediatric Hematology/Oncology
Thoracic Malignancies
Esophageal Cancer
Medical Oncology